Drug
Quabodepistat
Quabodepistat: highest development phase Phase 3, developed by Otsuka. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Otsuka
Trials
| Drug | Phase | Indication |
|---|---|---|
| Quabodepistat NCT07209761 | Phase 3 | Rifampicin-Resistant Pulmonary Tuberculosis |
Latest
No recent events.
Follow Quabodepistat on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.